SeterusnyaPanduan seterusnya
AI dalam Penapisan Autisme
industri
PANDUAN Industri
WHO recommends computer-aided detection (CAD) software as one option for interpreting chest X-rays in tuberculosis screening for defined populations and indications; it flags images for follow-up but does not confirm tuberculosis.
Dengar panduan iniAI-diceritakan · ~3 min
WHO’s 2025 evaluation identified products meeting performance standards for screening people aged 15 and older, without extending that result to younger children, and positive screens need diagnostic testing, and programs should report the population and workflow used and review local referral responsibilities.
Tuberculosis screening aims to identify people who may need diagnostic evaluation, including people without symptoms in higher-risk settings. Chest X-rays can support screening, and computer-aided detection software can score images for TB-related abnormalities. The World Health Organization has recommended CAD for TB screening and issued a 2025 policy statement reporting an independent evaluation of available products. That statement identifies software meeting WHO performance standards for screening people aged 15 and older; it does not extend that recommendation to children younger than 15. A screening score is not a confirmed TB diagnosis. A positive result should lead to further evaluation and diagnostic tests under the local program. An unreadable or missing image also needs a defined follow-up, not a default assumption of no disease. False positives can create unnecessary tests and anxiety; false negatives can delay treatment and allow ongoing transmission. CAD performance depends on image equipment, population, disease prevalence, and the threshold chosen by the program. Programs should use products and protocols consistent with current WHO guidance, validate local workflows, and make referral and confirmatory testing available. Explain that AI is used to help interpret the X-ray and state what happens after each result. Monitor image quality, thresholds, diagnostic yield, false alarms, and follow-up completion. Do not use CAD as a standalone diagnosis or apply adult recommendations to children without current evidence and guidance.
A screening program uses a WHO-evaluated CAD tool on chest X-rays for the population specified in current guidance.
A person with a positive CAD screen receives confirmatory testing rather than being told the AI has diagnosed TB.
A clinic reviews unreadable images and follows the program’s referral protocol rather than treating them as negative.
A public-health team monitors referral completion, false positives, and performance in the communities being screened.
CAD screening may expand as devices and software improve, but country-level implementation depends on capacity to confirm results and provide treatment. WHO may update evaluated products and recommendations, so programs should check current guidance. Include affected communities in design, explain how images and scores are used, and preserve human review and referral pathways. Screening performance should be assessed across settings, not assumed from a benchmark alone. Recheck referral capacity as programs grow and community needs change. Maintain diagnostic capacity for positive screens.
Newsletter percuma
Tiga cerita AI yang disahkan setiap pagi hari bekerja, ditulis dalam Bahasa Inggeris biasa. Percuma selamanya, tiada iklan.
Satu e-mel setiap hari bekerja. Berhenti melanggan dalam satu klik. Kami tidak pernah menjual atau berkongsi alamat anda.
Uji diri anda
Maklum balas segera pada setiap jawapan, dan sijil yang boleh dikongsi dengan ID yang boleh disahkan sebaik sahaja anda lulus kursus.
Sokong pendidikan AI percuma. AI Understanding ialah pertubuhan bukan keuntungan 501(c)(3) — tiada iklan, tiada bayaran dinding, selamanya. Buat derma
WHO recommends computer-aided detection (CAD) software as one option for interpreting chest X-rays in tuberculosis screening for defined populations and indications; it flags images for follow-up but does not confirm tuberculosis. WHO’s 2025 evaluation identified products meeting performance standards for screening people aged 15 and older, without extending that result to younger children, and positive screens need diagnostic testing, and programs should report the population and workflow used and review local referral responsibilities.
WHO describes CAD as an option to support chest X-ray screening, not confirmation.
The 2025 statement notes the evaluated recommendation applies to age 15 and older.
CAD is a screening aid; positive results need diagnostic testing.
Program quality depends on the full screening-to-diagnosis pathway.
Threshold performance depends on the population and screening context.
Teruskan belajar
Lebih banyak panduan dipilih untuk topik ini
SeterusnyaPanduan seterusnya
AI dalam Penapisan Autisme
industri